SCHEDULE 13D

Company

Lexaria Bioscience Corp.

Filed

December 21, 2011

Accession Number

0001062993-11-004998

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →